nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Diarrhoea—Tamoxifen—breast cancer	0.000927	0.000927	CcSEcCtD
Oritavancin—Infection—Gemcitabine—breast cancer	0.000925	0.000925	CcSEcCtD
Oritavancin—Dizziness—Vinblastine—breast cancer	0.000922	0.000922	CcSEcCtD
Oritavancin—Urticaria—Vinorelbine—breast cancer	0.00092	0.00092	CcSEcCtD
Oritavancin—Oedema peripheral—Docetaxel—breast cancer	0.000916	0.000916	CcSEcCtD
Oritavancin—Pruritus—Goserelin—breast cancer	0.000915	0.000915	CcSEcCtD
Oritavancin—Connective tissue disorder—Docetaxel—breast cancer	0.000914	0.000914	CcSEcCtD
Oritavancin—Nervous system disorder—Gemcitabine—breast cancer	0.000913	0.000913	CcSEcCtD
Oritavancin—Infection—Fluorouracil—breast cancer	0.000909	0.000909	CcSEcCtD
Oritavancin—Diarrhoea—Melphalan—breast cancer	0.000907	0.000907	CcSEcCtD
Oritavancin—Skin disorder—Gemcitabine—breast cancer	0.000904	0.000904	CcSEcCtD
Oritavancin—Nausea—Chlorambucil—breast cancer	0.000904	0.000904	CcSEcCtD
Oritavancin—Nervous system disorder—Fluorouracil—breast cancer	0.000897	0.000897	CcSEcCtD
Oritavancin—Dizziness—Tamoxifen—breast cancer	0.000896	0.000896	CcSEcCtD
Oritavancin—Tachycardia—Fluorouracil—breast cancer	0.000893	0.000893	CcSEcCtD
Oritavancin—Oedema peripheral—Capecitabine—breast cancer	0.000887	0.000887	CcSEcCtD
Oritavancin—Vomiting—Vinblastine—breast cancer	0.000886	0.000886	CcSEcCtD
Oritavancin—Diarrhoea—Goserelin—breast cancer	0.000885	0.000885	CcSEcCtD
Oritavancin—Connective tissue disorder—Capecitabine—breast cancer	0.000884	0.000884	CcSEcCtD
Oritavancin—Anaemia—Paclitaxel—breast cancer	0.000882	0.000882	CcSEcCtD
Oritavancin—Erythema multiforme—Docetaxel—breast cancer	0.000879	0.000879	CcSEcCtD
Oritavancin—Urticaria—Thiotepa—breast cancer	0.000879	0.000879	CcSEcCtD
Oritavancin—Headache—Vinblastine—breast cancer	0.000873	0.000873	CcSEcCtD
Oritavancin—Angioedema—Paclitaxel—breast cancer	0.000872	0.000872	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.00087	0.00087	CcSEcCtD
Oritavancin—Cardiac disorder—Docetaxel—breast cancer	0.000863	0.000863	CcSEcCtD
Oritavancin—Vomiting—Tamoxifen—breast cancer	0.000861	0.000861	CcSEcCtD
Oritavancin—Hypoglycaemia—Doxorubicin—breast cancer	0.000859	0.000859	CcSEcCtD
Oritavancin—Dizziness—Goserelin—breast cancer	0.000855	0.000855	CcSEcCtD
Oritavancin—Rash—Tamoxifen—breast cancer	0.000854	0.000854	CcSEcCtD
Oritavancin—Hypersensitivity—Vinorelbine—breast cancer	0.000854	0.000854	CcSEcCtD
Oritavancin—Dermatitis—Tamoxifen—breast cancer	0.000853	0.000853	CcSEcCtD
Oritavancin—Erythema multiforme—Capecitabine—breast cancer	0.000851	0.000851	CcSEcCtD
Oritavancin—Headache—Tamoxifen—breast cancer	0.000848	0.000848	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000848	0.000848	CcSEcCtD
Oritavancin—Vomiting—Melphalan—breast cancer	0.000843	0.000843	CcSEcCtD
Oritavancin—Immune system disorder—Docetaxel—breast cancer	0.00084	0.00084	CcSEcCtD
Oritavancin—Mediastinal disorder—Docetaxel—breast cancer	0.000838	0.000838	CcSEcCtD
Oritavancin—Rash—Melphalan—breast cancer	0.000836	0.000836	CcSEcCtD
Oritavancin—Cardiac disorder—Capecitabine—breast cancer	0.000835	0.000835	CcSEcCtD
Oritavancin—Dermatitis—Melphalan—breast cancer	0.000835	0.000835	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000834	0.000834	CcSEcCtD
Oritavancin—Eosinophilia—Methotrexate—breast cancer	0.000829	0.000829	CcSEcCtD
Oritavancin—Nausea—Vinblastine—breast cancer	0.000828	0.000828	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000825	0.000825	CcSEcCtD
Oritavancin—Vomiting—Goserelin—breast cancer	0.000822	0.000822	CcSEcCtD
Oritavancin—Pruritus—Vinorelbine—breast cancer	0.00082	0.00082	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Epirubicin—breast cancer	0.000816	0.000816	CcSEcCtD
Oritavancin—Rash—Goserelin—breast cancer	0.000816	0.000816	CcSEcCtD
Oritavancin—Hypersensitivity—Thiotepa—breast cancer	0.000815	0.000815	CcSEcCtD
Oritavancin—Dermatitis—Goserelin—breast cancer	0.000815	0.000815	CcSEcCtD
Oritavancin—Immune system disorder—Capecitabine—breast cancer	0.000813	0.000813	CcSEcCtD
Oritavancin—Myalgia—Paclitaxel—breast cancer	0.000813	0.000813	CcSEcCtD
Oritavancin—Mediastinal disorder—Capecitabine—breast cancer	0.000811	0.000811	CcSEcCtD
Oritavancin—Headache—Goserelin—breast cancer	0.00081	0.00081	CcSEcCtD
Oritavancin—Malnutrition—Docetaxel—breast cancer	0.000809	0.000809	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000807	0.000807	CcSEcCtD
Oritavancin—Nausea—Tamoxifen—breast cancer	0.000804	0.000804	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000803	0.000803	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Epirubicin—breast cancer	0.000799	0.000799	CcSEcCtD
Oritavancin—Diarrhoea—Vinorelbine—breast cancer	0.000793	0.000793	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00079	0.00079	CcSEcCtD
Oritavancin—Nausea—Melphalan—breast cancer	0.000788	0.000788	CcSEcCtD
Oritavancin—Malnutrition—Capecitabine—breast cancer	0.000784	0.000784	CcSEcCtD
Oritavancin—Pruritus—Thiotepa—breast cancer	0.000783	0.000783	CcSEcCtD
Oritavancin—Eosinophilia—Epirubicin—breast cancer	0.000776	0.000776	CcSEcCtD
Oritavancin—Infection—Paclitaxel—breast cancer	0.000774	0.000774	CcSEcCtD
Oritavancin—Nausea—Goserelin—breast cancer	0.000768	0.000768	CcSEcCtD
Oritavancin—Dizziness—Vinorelbine—breast cancer	0.000766	0.000766	CcSEcCtD
Oritavancin—Nervous system disorder—Paclitaxel—breast cancer	0.000764	0.000764	CcSEcCtD
Oritavancin—Tachycardia—Paclitaxel—breast cancer	0.00076	0.00076	CcSEcCtD
Oritavancin—Urticaria—Mitoxantrone—breast cancer	0.000759	0.000759	CcSEcCtD
Oritavancin—Diarrhoea—Thiotepa—breast cancer	0.000757	0.000757	CcSEcCtD
Oritavancin—Skin disorder—Paclitaxel—breast cancer	0.000757	0.000757	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.000755	0.000755	CcSEcCtD
Oritavancin—Anaemia—Docetaxel—breast cancer	0.000748	0.000748	CcSEcCtD
Oritavancin—Infestation—Methotrexate—breast cancer	0.000746	0.000746	CcSEcCtD
Oritavancin—Infestation NOS—Methotrexate—breast cancer	0.000746	0.000746	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Doxorubicin—breast cancer	0.00074	0.00074	CcSEcCtD
Oritavancin—Vomiting—Vinorelbine—breast cancer	0.000737	0.000737	CcSEcCtD
Oritavancin—Dizziness—Thiotepa—breast cancer	0.000732	0.000732	CcSEcCtD
Oritavancin—Rash—Vinorelbine—breast cancer	0.00073	0.00073	CcSEcCtD
Oritavancin—Dermatitis—Vinorelbine—breast cancer	0.00073	0.00073	CcSEcCtD
Oritavancin—Urticaria—Fluorouracil—breast cancer	0.000727	0.000727	CcSEcCtD
Oritavancin—Headache—Vinorelbine—breast cancer	0.000726	0.000726	CcSEcCtD
Oritavancin—Anaemia—Capecitabine—breast cancer	0.000724	0.000724	CcSEcCtD
Oritavancin—Eosinophilia—Doxorubicin—breast cancer	0.000718	0.000718	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.00071	0.00071	CcSEcCtD
Oritavancin—Hypersensitivity—Irinotecan—breast cancer	0.000704	0.000704	CcSEcCtD
Oritavancin—Hypersensitivity—Mitoxantrone—breast cancer	0.000704	0.000704	CcSEcCtD
Oritavancin—Vomiting—Thiotepa—breast cancer	0.000703	0.000703	CcSEcCtD
Oritavancin—Infestation—Epirubicin—breast cancer	0.000698	0.000698	CcSEcCtD
Oritavancin—Infestation NOS—Epirubicin—breast cancer	0.000698	0.000698	CcSEcCtD
Oritavancin—Rash—Thiotepa—breast cancer	0.000698	0.000698	CcSEcCtD
Oritavancin—Dermatitis—Thiotepa—breast cancer	0.000697	0.000697	CcSEcCtD
Oritavancin—Headache—Thiotepa—breast cancer	0.000693	0.000693	CcSEcCtD
Oritavancin—Myalgia—Docetaxel—breast cancer	0.000689	0.000689	CcSEcCtD
Oritavancin—Nausea—Vinorelbine—breast cancer	0.000688	0.000688	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000684	0.000684	CcSEcCtD
Oritavancin—Hypersensitivity—Fluorouracil—breast cancer	0.000674	0.000674	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000673	0.000673	CcSEcCtD
Oritavancin—Myalgia—Capecitabine—breast cancer	0.000667	0.000667	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000662	0.000662	CcSEcCtD
Oritavancin—Pruritus—Gemcitabine—breast cancer	0.000658	0.000658	CcSEcCtD
Oritavancin—Nausea—Thiotepa—breast cancer	0.000657	0.000657	CcSEcCtD
Oritavancin—Infection—Docetaxel—breast cancer	0.000656	0.000656	CcSEcCtD
Oritavancin—Diarrhoea—Irinotecan—breast cancer	0.000654	0.000654	CcSEcCtD
Oritavancin—Diarrhoea—Mitoxantrone—breast cancer	0.000654	0.000654	CcSEcCtD
Oritavancin—Nervous system disorder—Docetaxel—breast cancer	0.000648	0.000648	CcSEcCtD
Oritavancin—Pruritus—Fluorouracil—breast cancer	0.000647	0.000647	CcSEcCtD
Oritavancin—Infestation NOS—Doxorubicin—breast cancer	0.000646	0.000646	CcSEcCtD
Oritavancin—Infestation—Doxorubicin—breast cancer	0.000646	0.000646	CcSEcCtD
Oritavancin—Tachycardia—Docetaxel—breast cancer	0.000645	0.000645	CcSEcCtD
Oritavancin—Skin disorder—Docetaxel—breast cancer	0.000642	0.000642	CcSEcCtD
Oritavancin—Diarrhoea—Gemcitabine—breast cancer	0.000637	0.000637	CcSEcCtD
Oritavancin—Infection—Capecitabine—breast cancer	0.000635	0.000635	CcSEcCtD
Oritavancin—Erythema multiforme—Methotrexate—breast cancer	0.000634	0.000634	CcSEcCtD
Oritavancin—Dizziness—Irinotecan—breast cancer	0.000632	0.000632	CcSEcCtD
Oritavancin—Nervous system disorder—Capecitabine—breast cancer	0.000627	0.000627	CcSEcCtD
Oritavancin—Diarrhoea—Fluorouracil—breast cancer	0.000626	0.000626	CcSEcCtD
Oritavancin—Tachycardia—Capecitabine—breast cancer	0.000624	0.000624	CcSEcCtD
Oritavancin—Cardiac disorder—Methotrexate—breast cancer	0.000622	0.000622	CcSEcCtD
Oritavancin—Skin disorder—Capecitabine—breast cancer	0.000621	0.000621	CcSEcCtD
Oritavancin—Urticaria—Paclitaxel—breast cancer	0.000619	0.000619	CcSEcCtD
Oritavancin—Oedema peripheral—Epirubicin—breast cancer	0.000618	0.000618	CcSEcCtD
Oritavancin—Connective tissue disorder—Epirubicin—breast cancer	0.000616	0.000616	CcSEcCtD
Oritavancin—Vomiting—Irinotecan—breast cancer	0.000607	0.000607	CcSEcCtD
Oritavancin—Vomiting—Mitoxantrone—breast cancer	0.000607	0.000607	CcSEcCtD
Oritavancin—Immune system disorder—Methotrexate—breast cancer	0.000605	0.000605	CcSEcCtD
Oritavancin—Dizziness—Fluorouracil—breast cancer	0.000605	0.000605	CcSEcCtD
Oritavancin—Mediastinal disorder—Methotrexate—breast cancer	0.000604	0.000604	CcSEcCtD
Oritavancin—Rash—Mitoxantrone—breast cancer	0.000602	0.000602	CcSEcCtD
Oritavancin—Rash—Irinotecan—breast cancer	0.000602	0.000602	CcSEcCtD
Oritavancin—Dermatitis—Mitoxantrone—breast cancer	0.000602	0.000602	CcSEcCtD
Oritavancin—Dermatitis—Irinotecan—breast cancer	0.000602	0.000602	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000602	0.000602	CcSEcCtD
Oritavancin—Headache—Mitoxantrone—breast cancer	0.000599	0.000599	CcSEcCtD
Oritavancin—Headache—Irinotecan—breast cancer	0.000599	0.000599	CcSEcCtD
Oritavancin—Erythema multiforme—Epirubicin—breast cancer	0.000593	0.000593	CcSEcCtD
Oritavancin—Vomiting—Gemcitabine—breast cancer	0.000592	0.000592	CcSEcCtD
Oritavancin—Rash—Gemcitabine—breast cancer	0.000587	0.000587	CcSEcCtD
Oritavancin—Dermatitis—Gemcitabine—breast cancer	0.000586	0.000586	CcSEcCtD
Oritavancin—Malnutrition—Methotrexate—breast cancer	0.000583	0.000583	CcSEcCtD
Oritavancin—Headache—Gemcitabine—breast cancer	0.000583	0.000583	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000583	0.000583	CcSEcCtD
Oritavancin—Cardiac disorder—Epirubicin—breast cancer	0.000582	0.000582	CcSEcCtD
Oritavancin—Vomiting—Fluorouracil—breast cancer	0.000582	0.000582	CcSEcCtD
Oritavancin—Rash—Fluorouracil—breast cancer	0.000577	0.000577	CcSEcCtD
Oritavancin—Dermatitis—Fluorouracil—breast cancer	0.000576	0.000576	CcSEcCtD
Oritavancin—Hypersensitivity—Paclitaxel—breast cancer	0.000574	0.000574	CcSEcCtD
Oritavancin—Headache—Fluorouracil—breast cancer	0.000573	0.000573	CcSEcCtD
Oritavancin—Oedema peripheral—Doxorubicin—breast cancer	0.000572	0.000572	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Docetaxel—breast cancer	0.00057	0.00057	CcSEcCtD
Oritavancin—Connective tissue disorder—Doxorubicin—breast cancer	0.00057	0.00057	CcSEcCtD
Oritavancin—Nausea—Irinotecan—breast cancer	0.000568	0.000568	CcSEcCtD
Oritavancin—Nausea—Mitoxantrone—breast cancer	0.000568	0.000568	CcSEcCtD
Oritavancin—Immune system disorder—Epirubicin—breast cancer	0.000566	0.000566	CcSEcCtD
Oritavancin—Mediastinal disorder—Epirubicin—breast cancer	0.000565	0.000565	CcSEcCtD
Oritavancin—Nausea—Gemcitabine—breast cancer	0.000553	0.000553	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000552	0.000552	CcSEcCtD
Oritavancin—Pruritus—Paclitaxel—breast cancer	0.000551	0.000551	CcSEcCtD
Oritavancin—Erythema multiforme—Doxorubicin—breast cancer	0.000549	0.000549	CcSEcCtD
Oritavancin—Malnutrition—Epirubicin—breast cancer	0.000546	0.000546	CcSEcCtD
Oritavancin—Nausea—Fluorouracil—breast cancer	0.000544	0.000544	CcSEcCtD
Oritavancin—Anaemia—Methotrexate—breast cancer	0.000539	0.000539	CcSEcCtD
Oritavancin—Cardiac disorder—Doxorubicin—breast cancer	0.000538	0.000538	CcSEcCtD
Oritavancin—Diarrhoea—Paclitaxel—breast cancer	0.000533	0.000533	CcSEcCtD
Oritavancin—Immune system disorder—Doxorubicin—breast cancer	0.000524	0.000524	CcSEcCtD
Oritavancin—Mediastinal disorder—Doxorubicin—breast cancer	0.000523	0.000523	CcSEcCtD
Oritavancin—Dizziness—Paclitaxel—breast cancer	0.000515	0.000515	CcSEcCtD
Oritavancin—Urticaria—Capecitabine—breast cancer	0.000508	0.000508	CcSEcCtD
Oritavancin—Malnutrition—Doxorubicin—breast cancer	0.000505	0.000505	CcSEcCtD
Oritavancin—Anaemia—Epirubicin—breast cancer	0.000504	0.000504	CcSEcCtD
Oritavancin—Myalgia—Methotrexate—breast cancer	0.000497	0.000497	CcSEcCtD
Oritavancin—Vomiting—Paclitaxel—breast cancer	0.000495	0.000495	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000493	0.000493	CcSEcCtD
Oritavancin—Rash—Paclitaxel—breast cancer	0.000491	0.000491	CcSEcCtD
Oritavancin—Dermatitis—Paclitaxel—breast cancer	0.000491	0.000491	CcSEcCtD
Oritavancin—Headache—Paclitaxel—breast cancer	0.000488	0.000488	CcSEcCtD
Oritavancin—Hypersensitivity—Docetaxel—breast cancer	0.000487	0.000487	CcSEcCtD
Oritavancin—Infection—Methotrexate—breast cancer	0.000473	0.000473	CcSEcCtD
Oritavancin—Hypersensitivity—Capecitabine—breast cancer	0.000471	0.000471	CcSEcCtD
Oritavancin—Pruritus—Docetaxel—breast cancer	0.000467	0.000467	CcSEcCtD
Oritavancin—Nervous system disorder—Methotrexate—breast cancer	0.000467	0.000467	CcSEcCtD
Oritavancin—Anaemia—Doxorubicin—breast cancer	0.000467	0.000467	CcSEcCtD
Oritavancin—Myalgia—Epirubicin—breast cancer	0.000465	0.000465	CcSEcCtD
Oritavancin—Nausea—Paclitaxel—breast cancer	0.000463	0.000463	CcSEcCtD
Oritavancin—Skin disorder—Methotrexate—breast cancer	0.000462	0.000462	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000461	0.000461	CcSEcCtD
Oritavancin—Pruritus—Capecitabine—breast cancer	0.000452	0.000452	CcSEcCtD
Oritavancin—Diarrhoea—Docetaxel—breast cancer	0.000452	0.000452	CcSEcCtD
Oritavancin—Infection—Epirubicin—breast cancer	0.000443	0.000443	CcSEcCtD
Oritavancin—Diarrhoea—Capecitabine—breast cancer	0.000438	0.000438	CcSEcCtD
Oritavancin—Nervous system disorder—Epirubicin—breast cancer	0.000437	0.000437	CcSEcCtD
Oritavancin—Dizziness—Docetaxel—breast cancer	0.000437	0.000437	CcSEcCtD
Oritavancin—Tachycardia—Epirubicin—breast cancer	0.000435	0.000435	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000434	0.000434	CcSEcCtD
Oritavancin—Skin disorder—Epirubicin—breast cancer	0.000433	0.000433	CcSEcCtD
Oritavancin—Myalgia—Doxorubicin—breast cancer	0.00043	0.00043	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000427	0.000427	CcSEcCtD
Oritavancin—Dizziness—Capecitabine—breast cancer	0.000423	0.000423	CcSEcCtD
Oritavancin—Vomiting—Docetaxel—breast cancer	0.00042	0.00042	CcSEcCtD
Oritavancin—Rash—Docetaxel—breast cancer	0.000416	0.000416	CcSEcCtD
Oritavancin—Dermatitis—Docetaxel—breast cancer	0.000416	0.000416	CcSEcCtD
Oritavancin—Headache—Docetaxel—breast cancer	0.000414	0.000414	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000411	0.000411	CcSEcCtD
Oritavancin—Infection—Doxorubicin—breast cancer	0.000409	0.000409	CcSEcCtD
Oritavancin—Vomiting—Capecitabine—breast cancer	0.000407	0.000407	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000406	0.000406	CcSEcCtD
Oritavancin—Nervous system disorder—Doxorubicin—breast cancer	0.000404	0.000404	CcSEcCtD
Oritavancin—Rash—Capecitabine—breast cancer	0.000403	0.000403	CcSEcCtD
Oritavancin—Dermatitis—Capecitabine—breast cancer	0.000403	0.000403	CcSEcCtD
Oritavancin—Tachycardia—Doxorubicin—breast cancer	0.000402	0.000402	CcSEcCtD
Oritavancin—Headache—Capecitabine—breast cancer	0.000401	0.000401	CcSEcCtD
Oritavancin—Skin disorder—Doxorubicin—breast cancer	0.0004	0.0004	CcSEcCtD
Oritavancin—Nausea—Docetaxel—breast cancer	0.000392	0.000392	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000385	0.000385	CcSEcCtD
Oritavancin—Nausea—Capecitabine—breast cancer	0.00038	0.00038	CcSEcCtD
Oritavancin—Urticaria—Methotrexate—breast cancer	0.000378	0.000378	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000376	0.000376	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000356	0.000356	CcSEcCtD
Oritavancin—Urticaria—Epirubicin—breast cancer	0.000354	0.000354	CcSEcCtD
Oritavancin—Hypersensitivity—Methotrexate—breast cancer	0.000351	0.000351	CcSEcCtD
Oritavancin—Pruritus—Methotrexate—breast cancer	0.000337	0.000337	CcSEcCtD
Oritavancin—Hypersensitivity—Epirubicin—breast cancer	0.000328	0.000328	CcSEcCtD
Oritavancin—Urticaria—Doxorubicin—breast cancer	0.000327	0.000327	CcSEcCtD
Oritavancin—Diarrhoea—Methotrexate—breast cancer	0.000326	0.000326	CcSEcCtD
Oritavancin—Pruritus—Epirubicin—breast cancer	0.000315	0.000315	CcSEcCtD
Oritavancin—Dizziness—Methotrexate—breast cancer	0.000315	0.000315	CcSEcCtD
Oritavancin—Diarrhoea—Epirubicin—breast cancer	0.000305	0.000305	CcSEcCtD
Oritavancin—Hypersensitivity—Doxorubicin—breast cancer	0.000304	0.000304	CcSEcCtD
Oritavancin—Vomiting—Methotrexate—breast cancer	0.000303	0.000303	CcSEcCtD
Oritavancin—Rash—Methotrexate—breast cancer	0.0003	0.0003	CcSEcCtD
Oritavancin—Dermatitis—Methotrexate—breast cancer	0.0003	0.0003	CcSEcCtD
Oritavancin—Headache—Methotrexate—breast cancer	0.000298	0.000298	CcSEcCtD
Oritavancin—Dizziness—Epirubicin—breast cancer	0.000295	0.000295	CcSEcCtD
Oritavancin—Pruritus—Doxorubicin—breast cancer	0.000292	0.000292	CcSEcCtD
Oritavancin—Vomiting—Epirubicin—breast cancer	0.000283	0.000283	CcSEcCtD
Oritavancin—Nausea—Methotrexate—breast cancer	0.000283	0.000283	CcSEcCtD
Oritavancin—Diarrhoea—Doxorubicin—breast cancer	0.000282	0.000282	CcSEcCtD
Oritavancin—Rash—Epirubicin—breast cancer	0.000281	0.000281	CcSEcCtD
Oritavancin—Dermatitis—Epirubicin—breast cancer	0.000281	0.000281	CcSEcCtD
Oritavancin—Headache—Epirubicin—breast cancer	0.000279	0.000279	CcSEcCtD
Oritavancin—Dizziness—Doxorubicin—breast cancer	0.000273	0.000273	CcSEcCtD
Oritavancin—Nausea—Epirubicin—breast cancer	0.000265	0.000265	CcSEcCtD
Oritavancin—Vomiting—Doxorubicin—breast cancer	0.000262	0.000262	CcSEcCtD
Oritavancin—Rash—Doxorubicin—breast cancer	0.00026	0.00026	CcSEcCtD
Oritavancin—Dermatitis—Doxorubicin—breast cancer	0.00026	0.00026	CcSEcCtD
Oritavancin—Headache—Doxorubicin—breast cancer	0.000258	0.000258	CcSEcCtD
Oritavancin—Nausea—Doxorubicin—breast cancer	0.000245	0.000245	CcSEcCtD
